Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate nebulization in children with cystic fibrosis
IRCT20231031059919N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in cystic fibrosis (CF) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Forced expiratory volume in 1 second, Forced vital capacity and 3 more. Started Dec 2023; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on IRCT20231031059919N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231031059919N1.